王丽娜,毛拥军.藻酸双酯钠临床应用进展及不良反应[J].中国海洋药物,2015,34(1):67-72. |
藻酸双酯钠临床应用进展及不良反应 |
Progress in clinical applications of Propylene glycol alginate sodium sulfate and adverse reactions |
投稿时间:2014-09-05 修订日期:2014-10-23 |
DOI: |
中文关键词: 藻酸双酯钠 临床应用 不良反应 |
English Keywords:PSS clinical applications adverse reactions |
Fund Project: |
|
摘要点击次数: 4447 |
全文下载次数: 0 |
中文摘要: |
藻酸双酯钠为我国首次自主研发的海洋类多糖药物,已广泛投入临床应用,但近年来,不良反应时有报道,本文通过对藻酸双酯钠药理作用及近年来的临床应用、不良反应进行系统阐述,以期为藻酸双酯钠临床的合理应用提供参考,并为其开发安全新剂型、扩大临床适应症提供基础。 |
English Summary: |
As first self-developed marine polysaccharides drugs in China, propylene glycol alginate sodium sulfate (PSS) has been widely put into clinical applications. However,adverse reactions are reported in recent years. This article elaborates pharmacological effects, clinical applicationsins, and adverse reactions of PSS systematically,which provides references for the rational use of propylene glycol alginate sodium, and also provides a basis for the development of new formulations and expand clinical indications. |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |
|
|
|